Location · Encinitas, CA
Clinical trials in Encinitas, CA
9 recruiting studies have a site in Encinitas, and 3 of them accept healthy volunteers.
9 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd.
- Location
- Encinitas, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Urine Metabolites in the Diagnosis of Disease
Luventix, Inc.
- Location
- Encinitas, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2
Dose Regimen Study of SLI-F06 in Healthy Volunteers
Scarless Laboratories, Inc.
- Location
- Encinitas, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
AstraZeneca
- Location
- Encinitas, CA + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- Encinitas, CA + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Encinitas, CA + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Encinitas, CA + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Encinitas, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Encinitas, CA + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only